Effect of adjuvant radiotherapy on survival in resected pancreatic cancer: A propensity score surveillance, epidemiology, and end results database analysis

Journal of Surgical Oncology

Volumn 110, Issue 8, 2014, Pages 960-966

  Sugawara, Akitomo ^a   Kunieda, Etsuo ^b  

^a TOKAI UNIVERSITY HACHIOJI HOSPITAL   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Pancreatic neoplasm; Population based; Survival

Indexed keywords

ADJUVANT THERAPY; ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DATA ANALYSIS; DATA BASE; DISEASE SPECIFIC SURVIVAL; FEMALE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; POSTOPERATIVE PERIOD; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODEL; TREATMENT OUTCOME; AGED; CANCER REGISTRY; FACTUAL DATABASE; MIDDLE AGED; MORTALITY; PANCREATIC NEOPLASMS;

AGED; DATABASES, FACTUAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PROPENSITY SCORE; RADIOTHERAPY, ADJUVANT; SEER PROGRAM;

EID: 84910119746     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23752     Document Type: Article

References (27)

1. Siegel R, Naishadham D, Jemal A: Cancer statistics, 2013. CA Cancer J Clin 2013;63:11-30.
2. Cameron JL, Riall TS, Coleman J, et al.: One thousand consecutive pancreaticoduodenectomies. Ann Surg 2006;244:10-15.
3. Geer RJ, Brennan MF: Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 1993;165:68-72discussion 72-63.
4. Lim JE, Chien MW,Earle CC: Prognostic factors following curative resection for pancreatic adenocarcinoma: A population-based, linked database analysis of 396 patients. Ann Surg 2003;237: 74-85.
5. Allema JH, Reinders ME, van Gulik TM, et al.: Prognostic factors for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head region. Cancer 1995;75:2069-2076.
6. Mosca F, Giulianotti PC, Balestracci T, et al.: Long-term survival in pancreatic cancer: Pylorus-preserving versus Whipple pancreatoduodenectomy. Surgery 1997;122:553-566.
7. Nitecki SS, Sarr MG, Colby TV, et al.: Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg 1995;221:59-66.
8. Yeo CJ, Abrams RA, Grochow LB, et al.: Pancreaticoduodenectomy for pancreatic adenocarcinoma: Postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. Ann Surg 1997;225:621-633discussion 633-626.
9. Kalser MH, Ellenberg SS: Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 1985;120:899-903.
10. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Gastrointestinal Tumor Study Group. Cancer 1987;59:2006-2010.
11. Klinkenbijl JH, Jeekel J, Sahmoud T, et al.: Adjuvant radiotherapy and 5'fluorouracil after curative resection of cancer of the pancreas and periampullary region: Phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 1999;230:776-782discussion 782-774.
12. Neoptolemos JP, Dunn JA, Stocken DD, et al.: Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: A randomised controlled trial. Lancet 2001;358:1576-1585.
13. Neoptolemos JP, Stocken DD, Friess H, et al.: A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004;350:1200-1210.
14. Artinyan A, Hellan M, Mojica-Manosa P, et al.: Improved survival with adjuvant external-beam radiation therapy in lymph nodenegative pancreatic cancer: A United States population-based assessment. Cancer 2008;112:34-42.
15. Hazard L, Tward JD, Szabo A, et al.: Radiation therapy is associated with improved survival in patients with pancreatic adenocarcinoma: Results of a study from the Surveillance, Epidemiology, and End Results (SEER) registry data. Cancer 2007;110:2191-2201.
16. McDade TP, Hill JS, Simons JP, et al.: A national propensityadjusted analysis of adjuvant radiotherapy in the treatment of resected pancreatic adenocarcinoma. Cancer 2010;116:3257-3266.
17. Moody JS, Sawrie SM, Kozak KR, et al.: Adjuvant radiotherapy for pancreatic cancer is associated with a survival benefit primarily in stage IIB patients. J Gastroenterol 2009;44:84-91.
18. Opfermann KJ, Wahlquist AE, Garrett-Mayer E, et al.: Adjuvant radiotherapy and lymph node status for pancreatic cancer: Results of a study from the Surveillance, Epidemiology, and End Results (SEER) registry data. Am J Clin Oncol 2012.
19. Austin PC: A tutorial on the use of propensity score methods with survival or time-to-event outcomes: Reporting measures of effect similar to those used in randomized experiments. Stat Med 2013.
20. Rosenbaum PR: RD: Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. Am Stat. 1985;39:33-38.
21. Austin PC, Mamdani MM: A comparison of propensity score methods: A case-study estimating the effectiveness of post-AMI statin use. Stat Med 2006;25:2084-2106.
22. Rubin DB: The design versus the analysis of observational studies for causal effects: Parallels with the design of randomized trials. Stat Med 2007;26:20-36.
23. Austin PC, Grootendorst P, Anderson GM: A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: A Monte Carlo study. Stat Med 2007;26:734-753.
24. Klein JP, Moeschberger ML: "Survival analysis": Techniques for censored and truncated Data.". New York: Springer-Verlag 1997.
25. Agresti A, Min Y: Effects and non-effects of paired identical observations in comparing proportions with binary matched-pairs data. Stat Med 2004;23:65-75.
26. Lin DY, Psaty BM, Kronmal RA: Assessing the sensitivity of regression results to unmeasured confounders in observational studies. Biometrics 1998;54:948-963.
27. Mitra N, Heitjan DF: Sensitivity of the hazard ratio to nonignorable treatment assignment in an observational study. Stat Med 2007;26:1398-1414.